According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.21 B. In 2021 the company made a revenue of $0.19 B an increase over the years 2020 revenue that were of $83.13 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.21 B | 10.2% |
2021 | $0.19 B | 133.51% |
2020 | $83.13 M | 18.96% |
2019 | $69.88 M | 189.02% |
2018 | $24.18 M | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Merck MRK | $60.11 B | 27,998.40% | ๐บ๐ธ USA |
Lexicon Pharmaceuticals
LXRX | $1.2 M | -99.44% | ๐บ๐ธ USA |
Insmed INSM | $0.30 B | 42.66% | ๐บ๐ธ USA |